FDA Drug Recalls

Edgewell Personal Care Company (NYSE: EPC) is expanding its voluntary recall of Banana Boat Hair and Scalp Sunscreen. The consumer-level recall initially had three batches of the recall but now has an additional one. A review of the product found the presence of Benzene in the products. Unexpected levels of Benzene were discovered from the […]

Global Pharma Healthcare is issuing a voluntary nationwide recall of all lots within the expiry of their Artificial Tears Lubricant Eye Drops. The consumer-level recall is carried out due to possible contamination of the products distributed by /EzriCare, LLC- and Delsam Pharma. This recall was initiated after the Center for Disease Control and Prevention (CDC)

Spectrum Laboratory Products, Inc. has issued a voluntary recall of its Epinephrine (L-Adrenaline) USP Bulk Active Pharmaceutical Ingredient (API), Lot number LP5003, Expiration date 12/2020, due to the product being discolored. The user-level recall was initiated after consumer complaints of the products being discolored. Risk Statement Epinephrine is used to treat critical life-threatening conditions that

GFA Production (Xiamen) Co., Ltd issues a nationwide voluntary recall of Asy Care First Aid Burn Cream and First Aid Kits due to microbial contamination. The consumer-level recall was initiated after FDA testing revealed the presence of Bacillus licheniformis and Bacillus sonorensis in the products. Consumers can identify these products with their 0.9 g single-use

Lupin Pharmaceuticals is issuing a voluntary nationwide recall of four lots of Quinapril tablets due to the potential presence of an N-Nitroso-Quinapril impurity. N-Nitroso-Quinapril is a nitrosamine impurity identified as a probable human carcinogen based on laboratory testing. The recall was initiated after recent testing confirmed that the level of N-Nitroso-Quinapril impurity in the affected

Accord Healthcare Inc. has issued a voluntary nationwide recall of a single lot of Daptomycin for Injection 500 mg/vial and Daptomycin for Injection 350 mg/vial due to a product mix-up. The affected lot # R2200232 was distributed in cartons with an expiry date of 01/2025. The consumer-level recall was initiated after a hospital reported that